Skip to main content

Werewolf Therapeutics, Inc.

HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001785530

No open-market purchases or sales by Werewolf Therapeutics, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q3 2026, worth $11.9M in total; no superinvestor holds it.

Holders of 5% or more of HOWL

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Werewolf Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of HOWL
HolderLatest formStakeChangeFirst filedLatest filingFiling
Balyasny Asset Management LLC13G6.26%3.04M sharesNewNov 16, 20261 filingNov 16, 2026SEC
Moll Peter13G5.20%2.54M sharesNewSep 21, 20261 filingSep 21, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

43 Schedule 13D and 13G filings on Werewolf Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on HOWL
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 20266:03 AM ETBalyasny Asset Management LLCand 4 others13G6.26%3.04M sharesNewSep 30, 2026SEC
Sep 21, 202611:11 AM ETMoll Peter13G5.20%2.54M sharesNewSep 18, 2026SEC
Jul 2, 20268:26 PM ETRa Capital Management, L.P.and 3 others13D/A4.10%1.99M shares−1.90 ppfrom 6.00%Below 5%Jun 30, 2026SEC
Jun 26, 20265:39 PM ETRa Capital Management, L.P.and 3 others13D/A6.00%2.92M shares−1.50 ppfrom 7.50%Jun 24, 2026SEC
Jun 22, 20267:02 PM ETRa Capital Management, L.P.and 3 others13D/A7.50%3.65M shares−3.10 ppfrom 10.60%Jun 17, 2026SEC
Jun 15, 20268:16 PM ETRa Capital Management, L.P.and 3 others13D/A10.60%5.14M shares−2.00 ppfrom 12.60%Jun 11, 2026SEC
May 14, 20265:23 PM ETRa Capital Management, L.P.and 3 others13D/A12.60%6.12M shares−1.20 ppfrom 13.80%May 12, 2026SEC
May 12, 20267:56 PM ETMPM BioVentures 2014, L.P.and 13 others13D/A3.80%1.83M shares−1.60 ppfrom 5.40%Below 5%May 8, 2026SEC
May 5, 20267:04 PM ETMPM BioVentures 2014, L.P.and 13 others13D/A5.40%2.61M shares−1.50 ppfrom 6.90%May 1, 2026SEC
Feb 11, 20263:46 PM ETLongwood Fund III, L.P.and 1 other13G/A3.50%1.68M shares–Below 5%Dec 31, 2025SEC
Jan 16, 20265:36 PM ETMPM BioVentures 2014, L.P.and 13 others13D/A6.90%3.37M shares−1.30 ppfrom 8.20%Jan 14, 2026SEC
Dec 29, 20256:59 PM ETMPM BioVentures 2014, L.P.and 13 others13D/A8.20%3.98M shares−1.80 ppfrom 10.00%Dec 22, 2025SEC
Dec 3, 20257:04 PM ETMPM BioVentures 2014, L.P.and 13 others13D/A10.00%4.87M shares−1.30 ppfrom 11.30%Dec 1, 2025SEC
Nov 17, 20258:00 PM ETMPM BioVentures 2014, L.P.and 13 others13D/A11.30%5.48M shares−2.10 ppfrom 13.40%Nov 13, 2025SEC
Nov 6, 20254:29 PM ETRa Capital Management, L.P.and 3 others13D/A13.80%6.68M shares−1.20 ppfrom 15.00%Nov 4, 2025SEC
Nov 4, 20256:33 PM ETMPM BioVentures 2014, L.P.and 13 others13D/A13.40%6.15M shares–Oct 31, 2025SEC
Aug 14, 20254:48 PM ETPFM Health Sciences, LPand 3 others13G/A0.90%401.1K shares−5.60 ppfrom 6.50%Below 5%Jun 30, 2025SEC
May 14, 20256:09 PM ETRa Capital Management, L.P.and 3 others13D/A15.00%6.75M shares–May 12, 2025SEC
Feb 14, 20254:07 PM ETPFM Health Sciences, LPand 3 others13G/A6.50%2.91M shares–Dec 31, 2024SEC
Nov 14, 2024PFM Health Sciences, LP13G/AOld format–––SEC
Nov 14, 2024Bank of America Corp13G/AOld format–––SEC
Nov 13, 2024Rubric Capital Management LP13G/AOld format–––SEC
Nov 12, 2024Adage Capital Management, L.P.13G/AOld format–––SEC
May 7, 2024Ra Capital Management, L.P.13D/AOld format–––SEC
Feb 14, 2024Ra Capital Management, L.P.13D/AOld format–––SEC
Feb 14, 2024PFM Health Sciences, LP13G/AOld format–––SEC
Feb 13, 2024Bank of America Corp13GOld format–New–SEC
Feb 12, 2024Rubric Capital Management LP13G/AOld format–––SEC
Dec 21, 2023Adage Capital Partners GP, L.L.C.13GOld format–New–SEC
Feb 10, 2023Rubric Capital Management LP13GOld format–New–SEC
Jan 17, 2023PFM Health Sciences, LP13GOld format–––SEC
Jan 17, 2023PFM Health Sciences, LP13G/AOld format–––SEC
Jan 10, 2023Ra Capital Management, L.P.13D/AOld format–––SEC
Aug 12, 2022Ra Capital Management, L.P.13D/AOld format–––SEC
May 2, 2022PFM Health Sciences, LP13GOld format–New–SEC
Feb 11, 2022Flynn James E13G/AOld format–––SEC
Jun 16, 2021Ra Capital Management, L.P.13D/AOld format–––SEC
May 14, 2021MPM BioVentures 2014, L.P.13DOld format–New–SEC
May 14, 2021Longwood Fund III GP, LLC13GOld format–New–SEC
May 13, 2021Taiho Ventures LLC13DOld format–New–SEC
May 10, 2021Arkin Moshe13DOld format–New–SEC
May 6, 2021Ra Capital Management, L.P.13DOld format–New–SEC
May 4, 2021Flynn James E13GOld format–New–SEC

Form 144: proposed insider sales

114 notices from officers, directors and other affiliates planning to sell Werewolf Therapeutics, Inc. shares, newest first.

Form 144 notices for HOWL
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jul 6, 20265:19 PM ETMPM Oncology Innovations Fund, L.P.Shareholder21.2K$7.21KJul 6, 202610b5-1Merrill LynchSEC
Jul 6, 20265:19 PM ETMPM Asset Management Investors BV2014 LLCShareholder3.33K$1.13KJul 6, 202610b5-1Merrill LynchSEC
Jul 6, 20265:19 PM ETMPM Asset Management LLCShareholder15.3K$5.22KJul 6, 202610b5-1Merrill LynchSEC
Jul 6, 20265:18 PM ETUBS Oncology Impact Fund, L.P.Shareholder80.1K$27.3KJul 6, 202610b5-1Merrill LynchSEC
Jul 6, 20265:18 PM ETMPM BioVentures 2014 (B), L.P.Shareholder6.46K$2.20KJul 6, 202610b5-1Merrill LynchSEC
Jul 6, 20265:18 PM ETMPM BioVentures 2014, L.P.Shareholder96.9K$33.0KJul 6, 202610b5-1Merrill LynchSEC
Jun 29, 20265:30 PM ETMPM Oncology Innovations Fund, L.P.Shareholder23.2K$7.51KJun 29, 202610b5-1Merrill LynchSEC
Jun 29, 20265:30 PM ETMPM Asset Management Investors BV2014 LLCShareholder3.66K$1.18KJun 29, 202610b5-1Merrill LynchSEC
Jun 29, 20265:29 PM ETMPM Asset Management LLCShareholder16.8K$5.44KJun 29, 202610b5-1Merrill LynchSEC
Jun 29, 20265:29 PM ETUBS Oncology Impact Fund, L.P.Shareholder87.9K$28.4KJun 29, 202610b5-1Merrill LynchSEC
Jun 29, 20265:29 PM ETMPM BioVentures 2014 (B), L.P.Shareholder7.09K$2.29KJun 29, 202610b5-1Merrill LynchSEC
Jun 29, 20265:29 PM ETMPM BioVentures 2014, L.P.Shareholder106.3K$34.3KJun 29, 202610b5-1Merrill LynchSEC
May 28, 20265:04 PM ETMPM BioVentures 2014, L.P.Shareholder244.2K$119.7KMay 28, 202610b5-1Merrill LynchSEC
May 28, 20265:03 PM ETMPM BioVentures 2014 (B), L.P.Shareholder16.3K$7.98KMay 28, 202610b5-1Merrill LynchSEC
May 28, 20265:03 PM ETUBS Oncology Impact Fund, L.P.Shareholder202.0K$99.0KMay 28, 202610b5-1Merrill LynchSEC
May 28, 20265:03 PM ETMPM Asset Management LLCShareholder38.7K$19.0KMay 28, 202610b5-1Merrill LynchSEC
May 28, 20265:03 PM ETMPM Asset Management Investors BV2014 LLCShareholder8.40K$4.12KMay 28, 202610b5-1Merrill LynchSEC
May 28, 20265:02 PM ETMPM Oncology Innovations Fund, L.P.Shareholder53.4K$26.2KMay 28, 202610b5-1Merrill LynchSEC
May 18, 20265:03 PM ETMPM Oncology Innovations Fund, L.P.Shareholder63.5K$32.7KMay 18, 202610b5-1Merrill LynchSEC
May 18, 20265:02 PM ETMPM BioVentures 2014, L.P.Shareholder290.4K$149.6KMay 18, 202610b5-1Merrill LynchSEC
May 18, 20265:02 PM ETMPM BioVentures 2014 (B), L.P.Shareholder19.4K$9.98KMay 18, 202610b5-1Merrill LynchSEC
May 18, 20265:02 PM ETUBS Oncology Impact Fund, L.P.Shareholder240.3K$123.8KMay 18, 202610b5-1Merrill LynchSEC
May 18, 20265:01 PM ETMPM Asset Management LLCShareholder46.0K$23.7KMay 18, 202610b5-1Merrill LynchSEC
May 18, 20265:01 PM ETMPM Asset Management Investors BV2014 LLCShareholder10.0K$5.15KMay 18, 202610b5-1Merrill LynchSEC
May 11, 20264:33 PM ETMPM Oncology Innovations Fund, L.P.Shareholder18.5K$12.6KMay 11, 202610b5-1Merrill LynchSEC

Showing the latest 25. See the HOWL notices from the last 12 months